Condition
Tobacco Abuse Smoke
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02867514Not ApplicableUnknownPrimary
Effect of the Transcranial Direct Current Stimulation (tDCS) on Dependent Smoking People
NCT01216735Not ApplicableCompletedPrimary
Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers
NCT01735487Not ApplicableCompletedPrimary
CogEcig: Cognitive Functioning and Electronic Cigarette
NCT01665066Not ApplicableCompletedPrimary
Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes
Showing all 4 trials